Pluri (NASDAQ:PLUR) Director Purchases $2,086,956.22 in Stock

Pluri Inc. (NASDAQ:PLUR) Director Alexandre Weinstein Manieu acquired 452,702 shares of the company’s stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $4.61 per share, for a total transaction of $2,086,956.22. Following the completion of the purchase, the director owned 452,702 shares of the company’s stock, valued at $2,086,956.22. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Pluri Stock Performance

Shares of NASDAQ PLUR traded up $0.39 during midday trading on Thursday, reaching $3.96. 81,506 shares of the company were exchanged, compared to its average volume of 21,341. The stock has a market cap of $36.65 million, a P/E ratio of -0.77 and a beta of 0.63. Pluri Inc. has a 1 year low of $3.22 and a 1 year high of $7.13. The stock has a fifty day simple moving average of $4.23 and a 200 day simple moving average of $4.69. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 51.65.

Pluri (NASDAQ:PLUR) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($0.65) earnings per share for the quarter. The company had revenue of $0.32 million for the quarter. Pluri had a negative return on equity of 4,191.91% and a negative net margin of 1,701.19%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Pluri in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.00.

Institutional Trading of Pluri

A hedge fund recently bought a new stake in Pluri stock. Jane Street Group LLC purchased a new stake in shares of Pluri Inc. (NASDAQ:PLUR) in the first quarter, according to its most recent filing with the SEC. The firm purchased 10,928 shares of the company’s stock, valued at approximately $47,000. Jane Street Group LLC owned 0.14% of Pluri at the end of the most recent quarter. 16.59% of the stock is owned by institutional investors and hedge funds.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.